Mangrove Partners discloses updated portfolio positions in 13F filing: New AXAS GPRE CPRX positions
Highlights from 2017 Q4 filing as compared to 2017 Q3 filing:
- New positions in: AXAS (~3.34 mln shares), GPRE (~0.94 mln), CPRX (~0.92 mln), PDCE (~0.9 mln), METC (~0.29 mln), ALDX (~0.16 mln), FOX (~0.15 mln)
- Increased positions in: EQC (to ~2.34 mln shares from ~1.9 mln shares), INSW (to ~0.78 mln from ~0.4 mln), BCEI (to ~1.99 mln from ~1.7 mln), AER (to ~0.22 mln from ~0.12 mln), MYL (to ~0.91 mln from ~0.81 mln) BPT (to ~0.09 mln from ~0.07 mln),
- Maintained positions in: AT (~11.47 mln shares), CECO (~2.53 mln shares), SATS (~1.48 mln shares), PVAC (~1.44 mln shares), BTU (~0.96 mln shares), ANIP (~0.38 mln shares)
- Closed positions in: DRRX (from ~1.27 mln shares), HCC (from ~0.58 mln), EZPW (from ~0.34 mln), ALLY (from ~0.17 mln), QURE (from ~0.11 mln), ABG (from ~0.05 mln)
- Decreased positions in: SXC (to ~3.12 mln shares from ~6.36 mln shares)
